The Impact of the Mycoplasma pulmonis MALP-2 Homologue on Disease Progression
dc.contributor.advisor | Simecka, Jerry W. | |
dc.contributor.committeeMember | Hodge, Lisa M. | |
dc.contributor.committeeMember | Mathew, Porunelloor A. | |
dc.creator | Spear, Marcia G. | |
dc.date.accessioned | 2019-08-22T20:07:08Z | |
dc.date.available | 2019-08-22T20:07:08Z | |
dc.date.issued | 2008-04-01 | |
dc.date.submitted | 2014-04-01T09:12:05-07:00 | |
dc.description.abstract | Spear, Marcia. The Impact of Mycoplasma pulmonis MALP-2 Homologue on Disease Progression. Master of Science (Biomedical Sciences), April 2008. 64 pp., 3 tables, 8 illustrations. Using Mycoplasma pulmonis, this project looked at a possible critical component in mycoplasma disease, the MALP-2 homologue lipoprotein. Studies demonstrated other lipoproteins besides the MALP-2 homologue were critical for in vivo disease progression and in vitro macrophage IL-6, IL-12, and TNF-α cytokine production. This trend was also seen human endothelial kidney (HEK) cells transfected with toll-like receptor 1 (TLR2) and the heterodimer TLR2/6. An increase in IL-8 cytokine production seen in all stimulated HEK cell lines, indicating the lipoproteins involved in cell interactions are TLR2 mediated. This project suggests the M. pulmonis MALP-2 homologue is not the main lipoprotein involved in disease progression and cell interactions, indicating the MALP-2 homologue may not be an ideal target for vaccines or antibiotics. | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | https://hdl.handle.net/20.500.12503/27835 | |
dc.language.iso | en | |
dc.provenance.legacyDownloads | 0 | |
dc.subject | Bacteria | |
dc.subject | Bacterial Infections and Mycoses | |
dc.subject | Cell Anatomy | |
dc.subject | Cell and Developmental Biology | |
dc.subject | Cell Biology | |
dc.subject | Cells | |
dc.subject | Cellular and Molecular Physiology | |
dc.subject | Developmental Biology | |
dc.subject | Diseases | |
dc.subject | Immunology and Infectious Disease | |
dc.subject | Life Sciences | |
dc.subject | Medical Cell Biology | |
dc.subject | Medical Microbiology | |
dc.subject | Medical Molecular Biology | |
dc.subject | Medicine and Health Sciences | |
dc.subject | Other Cell and Developmental Biology | |
dc.subject | Virus Diseases | |
dc.subject | Mycoplasma pulmonis | |
dc.subject | MALP-2 | |
dc.subject | homologue | |
dc.subject | disease progression | |
dc.subject | impact | |
dc.subject | biomedical science | |
dc.subject | mycoplasma disease | |
dc.subject | lipoprotein | |
dc.subject | in vivo disease progression | |
dc.subject | in vitro macrophage | |
dc.subject | IL-6 | |
dc.subject | IL-12 | |
dc.subject | TNF-α cytokine | |
dc.subject | human endothelial kidney cells | |
dc.subject | M. pulmonis | |
dc.subject | cell interaction | |
dc.subject | vaccines | |
dc.subject | antibiotics | |
dc.title | The Impact of the Mycoplasma pulmonis MALP-2 Homologue on Disease Progression | |
dc.type | Thesis | |
dc.type.material | text | |
thesis.degree.department | Graduate School of Biomedical Sciences | |
thesis.degree.discipline | Biomedical Sciences | |
thesis.degree.grantor | University of North Texas Health Science Center at Fort Worth | |
thesis.degree.name | Master of Science |
Files
Original bundle
1 - 1 of 1